Predictive Oncology Inc. — Investor Relations & Filings

Predictive Oncology is a science-driven company that applies artificial intelligence (AI) and machine learning to oncology drug discovery and development. The company's core platform integrates its predictive AI engine with a proprietary biobank containing over 150,000 human tumor samples. This enables high-confidence predictions of drug response, helping biopharmaceutical partners de-risk development and select promising drug-tumor combinations in the pre-clinical phase. The company also provides advanced 3D tumor models that mimic the human physiological environment for more clinically relevant testing. Additionally, its clinical laboratory offers tumor drug-response and genomic biomarker testing services to support the personalization of cancer therapies.